Exponent, Inc. (EXPO) Stock
EXPO Key Statistics
About Exponent, Inc.
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
CEO: Catherine Ford Corrigan. Company website
EXPO — Frequently Asked Questions
What is the EXPO stock price today?
Exponent, Inc. (EXPO) trades at $68.30, up 0.16% on the day, as of Sep 20, 2026 14:57 UTC.
What is Exponent, Inc.'s market cap?
Exponent, Inc. has a market capitalisation of $3.31B, calculated from the live EXPO share price and shares outstanding.
What is the P/E ratio of EXPO?
EXPO trades at a trailing P/E of 30.63, from earnings per share of $2.23 over the last twelve months.
How much revenue does Exponent, Inc. make?
Exponent, Inc. generated revenue of $632.46M over the trailing twelve months, which puts the stock at 5.24 times sales.
What is the 52-week range for EXPO?
EXPO has traded between $51.91 and $81.95 over the past 52 weeks, and the last price is 16.7% below that high.
Is Exponent, Inc. profitable?
Yes. Exponent, Inc. keeps 17.67% of revenue as net income over the trailing twelve months.
What is the analyst price target for EXPO?
Wall Street analysts rate EXPO Buy, with an average price target of $72.00, 5.4% above the current price.
What sector is Exponent, Inc. in?
Exponent, Inc. is classified under the Industrials sector and the Engineering & Construction industry, and is domiciled in US.
Who is the CEO of Exponent, Inc.?
Catherine Ford Corrigan is the chief executive of Exponent, Inc., which employs 1,012 people.
Where can I track EXPO in real time?
QFI Terminal shows EXPO with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See EXPO live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open EXPO in Terminal See plans